finasteride has been researched along with Weight Gain in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abiola, OJ; Adaramoye, OA; Akanni, OO; Akinloye, O; Olapade-Olaopa, EO; Owumi, SE | 1 |
| Andrew, R; Barat, P; Di Rollo, EM; Livingstone, DE; MacFarlane, DP; Rees, GA; Rog-Zielinska, EA; Walker, BR; Weldin, BA | 1 |
| Goodman, P; Kristal, AR; Lucia, MS; Parnes, HL; Song, Y; Tangen, C; Thompson, IM | 1 |
| Carney, EW; Crissman, JW; Marty, MS | 1 |
1 trial(s) available for finasteride and Weight Gain
| Article | Year |
|---|---|
Finasteride, prostate cancer, and weight gain: evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatment.
Topics: Aged; Biopsy; Enzyme Inhibitors; Finasteride; Humans; Linear Models; Male; Middle Aged; Prostatic Neoplasms; Treatment Outcome; Weight Gain | 2008 |
3 other study(ies) available for finasteride and Weight Gain
| Article | Year |
|---|---|
Methyl jasmonate reduces testosterone-induced benign prostatic hyperplasia through regulation of inflammatory and apoptotic processes in rats.
Topics: Acetates; Animals; Apoptosis; Biomarkers; Cyclopentanes; Finasteride; Inflammation; Lipids; Male; Metabolic Detoxication, Phase I; Nitric Oxide; Organ Size; Oxylipins; Prostate; Prostatic Hyperplasia; Rats, Wistar; Testosterone; Weight Gain | 2017 |
5α-Reductase type 1 deficiency or inhibition predisposes to insulin resistance, hepatic steatosis, and liver fibrosis in rodents.
Topics: 5-alpha Reductase Inhibitors; Animals; Cholestenone 5 alpha-Reductase; Dietary Fats; Enzyme Assays; Fatty Liver; Finasteride; Insulin Resistance; Liver Cirrhosis; Male; Mice; Mice, Knockout; Rats; RNA, Messenger; Weight Gain | 2015 |
Evaluation of the EDSTAC female pubertal assay in CD rats using 17beta-estradiol, steroid biosynthesis inhibitors, and a thyroid inhibitor.
Topics: 5-alpha Reductase Inhibitors; Animals; Antineoplastic Agents, Hormonal; Antithyroid Agents; Endocrine Glands; Enzyme Inhibitors; Estradiol; Evaluation Studies as Topic; Fadrozole; Female; Finasteride; Ketoconazole; Male; Organ Size; Propylthiouracil; Rats; Rats, Inbred Strains; Sexual Maturation; Steroids; Testolactone; Thyroid Hormones; Toxicology; Uterus; Weight Gain | 1999 |